Anglikang is a modern pharmaceutical company specializing in the health of Chinese people, featuring oral cephalosporins, cardiovascular and kidney diseases.
In the future development, Anglikang will adhere to the two-wheel drive of technological transformation and product innovation, and build the company into an innovative international enterprise with strong comprehensive competitiveness in the industry.
Anglikang core values: integrity, passion, professionalism, respect, cooperation
Anglikang always insists on technological innovation to drive enterprise development and continuously invests a large amount of research and development funds. 
Anglikang always adheres to the people-oriented principle and introduces talents without any restrictions.
Products
Integrity, passion, professionalism, respect and cooperation
Address: No. 1000, North of Shengzhou Avenue, Shengzhou City, Zhejiang Province, China
Tel: +86-575-83123228
Fax: +86-575-83101736
E-mail: hr@alkpharm.cn
URL: http://www.alkpharm.com
2.5mg-7 tablets-2 boards Levamlodipine Besylate Tablets
Levamlodipine Besylate Tablets Insturctions
Please read the instructions carefully and use them under the guidance of physician.
[Drug name]
Common name: Levamlodipine Besylate Tablets
English name: Levamlodipine Besylate Tablets
Chinese Pinyin: Benhuangsuan Zuoxuan’anlüdiping Pian
[Ingredients]
The active ingredient of this product is levamlodipine besylate.Chemical name: (S)-(-)-3-ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6- Base-3,5-pyridinedicarboxylate besylate.
Structural formula:
Molecular formula: C20H25 N2O5 Cl ×C6H6O3S
Molecular weight: 567.05
[Properties]
White tablets.
[Indications]
(1)High blood pressure(2)Angina.
[Specifications]
2.5mg(calculated as L-amlodipine)
[Usage and dosage]
(1)The initial dose for the treatment of hypertension and angina is 2.5 mg (1 tablet), once a day;Depending on the patient's clinical response, the dose can be increased to a maximum of 5 mg (2 tablets) once a day.
(2)Dose adjustment is not required when combined with thiazide diuretic, beta blocker and angiotensin converting enzyme inhibitor.
[Taboo]
It is contraindicated in patients with hypersensitivity to dihydropyridine calcium antagonists.
[Use in pregnant and lactating women]
This product is recommended only if there is no other safer alternative to the drug and the disease itself is more dangerous to the mother and child.
[Use in children]
No information is available on this product for children.
[Use in the elderly]
Normal doses in older patients.
[Storage]
Store in a well-closed container in shading place (under 20℃).
[Packing]
Aluminum-plastic blister packaging, 7 tablets×1 board / box, 7 tablets×2 boards/ box，7 tablets×4 boards/box, 10 tablets×1 board / box, 10 tablets×2 boards/ box.
[Validity period]
24 months
[Executive standards]
YBH05882008
[Approval Number]
State Medical Permitment No. H20083460
[Manufacturer]
Enterprise: Zhejiang Anglikang Pharmaceutical Co., Ltd.
Production address: No. 1000, North of Shengzhou Avenue, Shengzhou City, Shaoxing City, Zhejiang, China
P. C.: 312400
Tel: +86-575-83108588
Fax: +86-575-83101736
